Function of Beta Blockers
Beta blockers primarily work by competitively blocking the effects of catecholamines (adrenaline and noradrenaline) on beta-adrenergic receptors, reducing heart rate, myocardial contractility, and blood pressure, which decreases myocardial oxygen demand and improves outcomes in various cardiovascular conditions. 1
Mechanism of Action
Beta blockers target specific receptors in the body:
Beta-1 receptors - Located primarily in the myocardium (heart muscle)
- Blocking these receptors reduces:
- Myocardial contractility (heart's pumping force)
- Sinus node rate (heart rate)
- AV node conduction velocity (electrical impulse conduction)
- Systolic blood pressure 1
- Blocking these receptors reduces:
Beta-2 receptors - Located primarily in vascular and bronchial smooth muscle
- Blocking these receptors can cause:
- Vasoconstriction
- Bronchoconstriction (particularly with non-selective beta blockers) 1
- Blocking these receptors can cause:
Beta-3 receptors - Some newer beta blockers interact with these receptors for additional effects 2
Physiological Effects
Beta blockers produce several important cardiovascular effects:
- Reduced heart rate - Blunts response to exertion, stress, and pain
- Decreased myocardial contractility - Reduces cardiac workload
- Lowered blood pressure - Through multiple mechanisms
- Prolonged diastole - Increases coronary perfusion time
- Reduced myocardial oxygen demand - Key benefit in conditions like angina 1
Clinical Applications
Beta blockers are indicated for several conditions:
- Angina pectoris - Increase exercise tolerance and reduce symptoms 1
- Post-myocardial infarction - Reduce mortality 3
- Heart failure - Improve outcomes when carefully titrated 3
- Hypertension with specific comorbidities - Not first-line for uncomplicated hypertension 3
- Tachyarrhythmias - Provide rate control 3
- Aortic dissection - Help control blood pressure and heart rate 1
Types of Beta Blockers
Beta blockers are classified into three generations:
Non-selective beta blockers (e.g., propranolol)
- Block both beta-1 and beta-2 receptors
- Greater risk of bronchospasm and peripheral vasoconstriction 2
Cardioselective beta blockers (e.g., metoprolol, atenolol, bisoprolol)
- Preferentially block beta-1 receptors
- Better tolerated in patients with respiratory conditions
- Selectivity is dose-dependent and diminishes at higher doses 3
Vasodilating beta blockers (e.g., carvedilol, nebivolol)
- Block beta-1 receptors plus additional vasodilatory effects
- May have more favorable hemodynamic profiles 4
Important Considerations and Precautions
- Abrupt discontinuation risks - Can cause rebound hypertension, tachycardia, and exacerbation of angina 5, 6
- Heart failure considerations - May initially worsen heart failure but improve long-term outcomes when properly titrated 5
- Respiratory disease - Use cardioselective agents with caution in patients with respiratory conditions 3
- Diabetes - May mask symptoms of hypoglycemia (particularly tachycardia) 6
- Surgery - Generally should not be routinely withdrawn before major surgery 6
- Thyrotoxicosis - May mask symptoms; abrupt withdrawal can precipitate thyroid storm 6
Common Side Effects
- Cold extremities
- Symptomatic bradycardia
- Fatigue
- Respiratory symptoms (especially with non-selective agents)
- Sleep disturbances
- Sexual dysfunction 1
Beta blockers remain a cornerstone of cardiovascular therapy, though their role has evolved over time with better understanding of their benefits and limitations in different patient populations.